→ これまでのがん治療薬は見当違いの対象を攻撃していた可能性が高い
→ Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
→ Many cancer drugs aim at the wrong molecular targets
→ Why Aren’t Cancer Drugs Better? The Targets Might Be Wrong
